Three-dimensional bioprinting with decellularized extracellular matrix-based bioinks in translational regenerative medicine
MRS Bulletin, ISSN: 0883-7694, Vol: 47, Issue: 1, Page: 70-79
2022
- 20Citations
- 30Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
In recent years, three-dimensional (3D) bioprinting has made considerable advancements in tissue engineering and regenerative medicine and has emerged as a vital tool for creating functional living tissue/organ systems. Apart from technological advances, combining decellularized extracellular matrix (dECM) methodologies with 3D bioprinting has resulted in significant progressions in developing highly biomimetic and reliable tissue/organ platforms for translational regenerative medicine. This review provides a comprehensive overview of the translation of 3D bioprinting techniques in various tissue engineering applications, while emphasizing the use of dECM-based bioinks. First, we introduce the 3D bioprinting technique and dECM methodologies to develop bioink and describe the key considerations when performing a 3D bioprinting process. Further, we discuss the recent progress of dECM bioinks combined with 3D bioprinting in the fabrication of different types of tissue constructs for in vivo tissue regeneration and in vitro modeling. Lastly, we describe the key challenges and future perspectives of dECM-based 3D bioprinting technology for clinical use. Graphical abstract: [Figure not available: see fulltext.]
Bibliographic Details
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know